WELCOME TO THE AICARDI SYNDROME COMMUNITY: This Patient-To-Patient Community is for discussions relating to Aicardi Syndrome, which is a rare genetic disorder that primarily affects newborn girls, and is often characterized by partial or complete absence of the structure that links the two sides of the brain (corpus callosum), complex seizures and retinal lacunae which are lesions on the retina.
For support and advice from others, visit our Aicardi Syndrome Community
Aicardi syndrome is a rare genetic disorder that primarily affects newborn
girls. The condition is sporadic, meaning it is not known to pass from parent
to child. (An exception is a report of two sisters and a pair of identical
twins, all of whom were affected.) The mutation that causes Aicardi syndrome
has not been identified. Scientists believe that the gene associated with the
condition is located on the X chromosome because nearly all affected
individuals are female and the only reports of boys having Aicardi syndrome are
in boys born with an extra "X" chromosome. (Females have two X
chromosomes, while males normally have an X and a Y chromosome.) Girls with
Aicardi syndrome often develop seizures prior to three months and most before
one year of age.
Originally, Aicardi syndrome was characterized by three main features: 1) partial or complete absence of the structure (corpus callosum) that links the two halves of the brain (2) complex seizures, generally starting as infantile spasms, and 3) retinal lacunae, lesions on the retina that look like yellowish spots. However, Aicardi syndrome is now known to have a much broader spectrum of abnormalities than was initially described. Not all girls with the condition have the three features described above and many girls have additional features.
Typical findings in the brain of girls with Aicardi syndrome include heterotopias, which are groups of brain cells that, during development, migrated to the wrong area of brain; polymicrogyria or pachygyria, which are numerous small, or too few, brain folds; and cysts, (fluid filled cavities) in the brain. Girls with Aicardi syndrome have varying degrees of mental retardation and developmental delay. Many girls also have developmental abnormalities of their optic nerves and some have microphthalmia (small eyes). Skeletal problems such as absent or abnormal ribs and abnormalities of vertebrae in the spinal column (including hemivertebrae and butterfly vertebrae) have also been reported. Some girls also have skin problems, facial asymmetry, or other characteristic facial features.
(Aicardi syndrome is distinct from Aicardi-Goutieres syndrome, which is an inherited encephalopathy that affects newborn infants.)
There is no cure for Aicardi syndrome nor is there a standard course of treatment. Treatment generally involves medical management of seizures and programs to help parents and children cope with developmental delays. Long-term management by a pediatric neurologist with expertise in the management of infantile spasms is recommended.
The prognosis for girls with Aicardi syndrome varies according to the severity of their symptoms. There is an increased risk for death in childhood and adolescence, but survivors into adulthood have been described.
The NINDS supports and conducts research on neurogenetic disorders such as
Aicardi syndrome. The goals of this research are to locate and understand the
genes involved and to develop techniques to diagnose, treat, prevent, and
ultimately cure disorders such as Aicardi syndrome.
Source: Information provided courtesy of the National Institute of Neurological Disorders and Stroke (NINDS), a division of the National Institutes of Health (NIH).
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.